SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-10-002485
Filing Date
2010-10-19
Accepted
2010-10-19 17:18:03
Documents
2
Period of Report
2010-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LOTUS PHARMACEUTICALS, INC FORM 8-K form8k.htm 8-K 30959
2 EXHIBIT 99.1 ex991.htm EX-99.1 2743
  Complete submission text file 0001013762-10-002485.txt   35481
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

IRS No.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32581 | Film No.: 101131028
SIC: 2834 Pharmaceutical Preparations